| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.12B | +4.1% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥-0.00B | — |
| Gross margin | 34.9% | Net margin -0.9% |
| Revenue Q/Q | -58.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 65.1% |
| R&D | ¥0.01B | 12.5% |
| SG&A | ¥0.04B | 30.6% |
| Tax & other | ¥0.00B | 0.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
杰恩股份 ・ 沪宁股份 ・ 大烨智能 ・ 富满微 ・ 国科微 ・ 佩蒂股份 ・ 宇信科技 ・ 建科院 ・ 华大基因 ・ 英科医疗 ・ 中科信息 ・ 电连技术
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies